Can You Sell a Survey Instrument Developed Under a Federal Award?

TL;DR

Overview

This guide is for researchers, principal investigators, technology transfer officers, and sponsored programs administrators at universities, nonprofits, and small businesses that receive federal grants and want to commercialize a survey instrument developed under that funding.

We cover: what qualifies as a survey instrument under federal awards, who owns the IP and why, the copyright framework under 2 CFR 200.315, when the Bayh-Dole Act comes into play, what "can sale of a survey instrument developed in the scope of work of a federal award" actually mean in practice, the program income rules, the permanent federal license you cannot eliminate, common pitfalls, and a practical checklist for commercializing safely.

What Is a Survey Instrument in a Federal Award?

A survey instrument, in the federal grants context, is any structured data-collection tool developed as part of the funded research. This includes:

• Validated questionnaires and psychometric scales
• Interview protocols and structured observation checklists
• Assessment tools for clinical or educational settings
• Electronic survey platforms or software instruments
• Data collection forms designed for a specific research population

The key phrase is "developed in the scope of work." If creation of the instrument was listed in the statement of work, funded by grant dollars, or the instrument emerged from research activities that the award supported, it falls under the award's IP provisions.

Instruments developed entirely with non-federal funds — even during the grant period — are generally outside the award's IP provisions. The closer the instrument's development is to the funded scope of work, the more clearly the federal rules apply.

Who Owns the IP? The Starting Point

The default rule under 2 CFR 200.315(a) is clear: "Title to intangible property acquired under a Federal award vests upon acquisition in the recipient or subrecipient."

The federal government does not own your survey instrument simply because federal money funded its development. The recipient — the university, nonprofit, or company that received the award — owns it.

This is a common misconception. Researchers often assume the government owns whatever they create with federal funds. That is not what the regulations say. Ownership vests in the recipient. The government's interest is a license, not ownership.

There are two primary IP frameworks that shape what the recipient can do with that ownership: the copyright provisions under 2 CFR 200.315(b) and the patent provisions under the Bayh-Dole Act.

Copyright Under 2 CFR 200.315

Section 200.315(b) states: "The recipient or subrecipient may copyright any work that is subject to copyright and was developed, or for which ownership was acquired, under a Federal award."

This covers survey instruments that are original creative works — questionnaires, scales, protocols, assessment tools. Copyright protection attaches automatically at creation. The recipient holds the copyright and can:

• Register the copyright with the U.S. Copyright Office
• Sell the copyright outright to a third party
• License the instrument exclusively or non-exclusively
• Commercialize it through a publisher or directly

The constraint is the federal purpose license — the government's retained right to use the instrument for federal purposes, which cannot be eliminated regardless of what commercial deal you sign.

The Bayh-Dole Act: When Patents Apply

The Bayh-Dole Act (35 U.S.C. §200–212), implemented at 37 CFR 401, governs patents on federally funded inventions — not copyrights.

A "subject invention" under Bayh-Dole is "any invention of the contractor that is conceived or first actually reduced to practice in the performance of work under a funding agreement." Most survey questionnaires and research protocols are not patentable. They are literary works protected by copyright.

Bayh-Dole becomes relevant if your survey instrument includes:

• A novel algorithm or software that qualifies as a patentable invention
• A physical device or sensing technology embedded in the instrument
• A biological method or process claimed as a novel discovery

If any component of your instrument crosses into patentable territory, you must disclose it to the funding agency within two months of conception or reduction to practice, elect to retain title, and file a patent application within one year of election. Failure to disclose forfeits your rights. This is where most researchers make costly mistakes.

Can You Sell a Federally Funded Survey Instrument?

Yes — the sale of a survey instrument developed in the scope of work of a federal award is permitted under the standard federal grant framework. The regulations do not prohibit commercialization. They structure it.

What "sale" can mean in practice:

The key constraint: you cannot encumber the instrument — pledge it as collateral, for instance — without agency approval during the award period. And you cannot strip the federal government of its permanent non-exclusive license, regardless of who buys the copyright.

Everything else — licensing it, selling it, publishing it commercially — is within the recipient's rights under the standard federal grant framework.

Program Income Rules: What Happens to the Money

Program income under 2 CFR 200.307 is gross income earned by the recipient during the period of performance that is directly generated by a supported activity or earned as a result of a federal award.

The critical exclusion for survey instrument sales: "License fees and royalties for copyrighted material, patents, patent applications, trademarks, and inventions made under the Federal award" are explicitly excluded from program income treatment. Recipients are not accountable to the federal agency for those proceeds.

In practice, this means:

• Royalties from licensing a copyrighted survey instrument — not program income. The recipient keeps 100% (subject to institutional policies on revenue sharing with inventors).
• License fees paid upfront for rights to use the instrument — not program income if they qualify as copyright license fees.
• Revenue from selling physical copies or printed forms — may be treated as program income from the "sale of commodities or items fabricated under a Federal award." Check with your grants office.
• Income earned after the period of performance ends — no program income obligations at all under 2 CFR 200.307, unless the award terms say otherwise.

The program income rules have three permitted application methods — deduction (income reduces allowable costs), addition (income increases the project budget), or cost sharing. If your income does qualify as program income, your grant officer will tell you which method applies. For licensing-based revenue from copyrighted works, this question typically does not arise.

The Federal Purpose License: What the Government Keeps

Every recipient who develops a copyrightable work under a federal award grants the federal government a permanent right: "a royalty-free, nonexclusive, and irrevocable right to reproduce, publish, or otherwise use the work for Federal purposes and to authorize others to do so."

This federal purpose license is not negotiable. It attaches to the work at creation. It cannot be purchased away, excluded in a licensing deal, or expired. Any commercial buyer of your survey instrument's copyright takes ownership subject to this license.

What "federal purposes" means in practice:

• Federal agencies can use the instrument in their own research programs
• Federal agencies can authorize other federal grantees to use it in federally funded projects
• Federal agencies can reproduce and distribute the instrument for official government purposes

What it does not mean:

• The government cannot sell or commercialize the instrument on its own
• The government cannot grant a commercial license to private parties for commercial use
• The government's license does not prevent you from licensing or selling commercially

For most commercialization scenarios, the federal purpose license is not a practical obstacle. Commercial buyers understand it. Publishers routinely acquire instruments subject to it. The license only creates problems if a buyer incorrectly believes they are purchasing an exclusive right to prevent all government use — which they are not.

Common Pitfalls and How to Avoid Them

1. Not Disclosing a Patentable Component

If any part of your survey instrument qualifies as a subject invention under Bayh-Dole — a novel algorithm, a patentable method — and you fail to disclose it to the agency within two months, you risk losing your right to retain title. The agency can then take title. Disclose early, even if you are uncertain whether the component meets the patent threshold.

2. Selling Exclusive Rights Without Noting the Federal License

Commercial buyers expect clear title. If you sell or exclusively license the copyright without disclosing the federal purpose license, the buyer may discover it during due diligence and challenge the deal. Always disclose the federal purpose license upfront in any term sheet or licensing agreement. Frame it accurately — it is a non-exclusive license for federal use only, not a competing commercial license.

3. Treating All Revenue as Tax-Free or Unrestricted

The program income exclusion for copyright royalties means the agency does not have a claim on those proceeds — but your institution does. Most universities and nonprofits have inventor-sharing policies that split commercialization revenue between the inventor, the department, and the institution. Revenue from a federally funded instrument is typically subject to those policies even when it is excluded from program income under federal rules.

4. Assuming the Rules Are the Same for Contracts and Grants

The 2 CFR 200 framework applies to grants and cooperative agreements. Federal contracts use the Federal Acquisition Regulation (FAR) data rights clauses, which can give the government "unlimited rights" or "government purpose rights" in technical data — rights that are substantially broader than the federal purpose license under 2 CFR 200.315. If your instrument was developed under a contract (not a grant), the IP analysis is different. Review the contract's data rights clause specifically.

5. Waiting Until After the Award Ends to Get Clarity

Post-award commercialization is simpler — no program income obligations. But the time to get IP strategy right is during the award period, before you've had commercialization conversations that complicate the picture. Involve your institution's sponsored programs office and technology transfer office early. Late discovery of a Bayh-Dole disclosure obligation can jeopardize a deal that's already in progress.

Practical Steps Before You Sell

Before pursuing any commercial sale or licensing deal for a federally funded survey instrument, work through this checklist:

1. Identify your funding instrument. Is it a grant, cooperative agreement, or contract? The applicable IP rules differ. Grants and cooperative agreements use 2 CFR 200. Federal contracts use FAR data rights clauses. Check the award document header and any special terms and conditions for IP provisions.
2. Classify your instrument's IP type. Is it copyright-protected (most survey questionnaires), patent-eligible (novel algorithms, devices), or trade secret? The commercialization path differs for each. Copyright-protected instruments have the most flexibility under federal grant rules.
3. Check for Bayh-Dole disclosure obligations. If any component is potentially patentable and was conceived or reduced to practice under the funded scope of work, notify your technology transfer office immediately. Disclosure timelines are mandatory.
4. Review your award's specific IP terms. Many agencies add special IP terms beyond the standard 2 CFR 200 provisions. NIH, NSF, DoE, and DoD each have agency-specific policies. The award notice, terms and conditions, and any agency-specific requirements documents are the authoritative source.
5. Engage your institution's technology transfer office. For universities and research nonprofits, the technology transfer office (TTO) owns the IP rights on behalf of the institution — not the individual PI. The TTO executes licensing agreements. Individual researchers cannot independently sign commercial deals for institutionally owned IP.
6. Structure the deal to accommodate the federal purpose license. Draft any licensing agreement to explicitly carve out the government's non-exclusive license for federal purposes. Buyers and their counsel expect this. Address it proactively rather than having it surface as a deal risk during due diligence.
7. Document the instrument's development history. Keep a clear record of what was developed with federal funds vs. what existed before or was developed with non-federal resources. Mixed-funding situations create mixed-ownership questions. Documentation protects your commercialization position.

For a useful parallel on how federal rules affect other types of sales involving government programs, the guide on USDA rural development loans and for-sale-by-owner homes illustrates how federal program conditions shape commercial transactions in other domains.

How SyncGTM Fits Into Research Commercialization

Technology transfer offices and research commercialization teams face a GTM problem: identifying potential licensees, reaching them, and running a structured outreach process to convert interest into signed deals. The IP framework is clear. The sales motion often is not.

SyncGTM is the GTM platform research commercialization teams use to build and work their prospect lists for licensing deals. Specifically:

• Prospect enrichment: Identify companies, publishers, and research organizations that would benefit from your instrument. Waterfall enrichment against 50+ data sources verifies contact data so outreach actually reaches decision-makers.
• Automated outreach sequences: Build multi-touch sequences for licensing conversations — initial introduction, follow-up with use case examples, meeting requests — with personalization at scale.
• CRM integration: Push licensing prospects directly into HubSpot or Salesforce with relevant context attached, so no opportunity falls through the cracks during a long deal cycle.

The challenge of commercializing research is rarely the IP clarity — it is building a disciplined sales process around it. The guide on how to develop a corporate sales plan applies directly to structuring a TTO's licensing outreach.

For the outreach side, see the guide on personalizing sales emails — the same principles apply to licensing outreach to publishers and commercial buyers. And for building a repeatable pipeline, the overview of B2B sales prospecting tools covers the full toolkit.

For organizations scaling research commercialization across multiple instruments and deals, the guide on managing a B2B sales pipeline provides the operational framework.

SyncGTM pricing starts at $0 for solo operators — no per-seat minimums, no lock-in.

Conclusion

Can sale of a survey instrument developed in the scope of work of a federal award proceed? Yes — and the federal regulatory framework actively supports it.

Under 2 CFR 200.315, recipients own the copyright to works developed under federal awards. The government holds a permanent, royalty-free, non-exclusive license for federal purposes — but it does not own the instrument, and that license does not block commercial sale or licensing.

Under 2 CFR 200.307, license fees and royalties from copyrighted works made under federal awards are excluded from program income — meaning recipients owe the agency nothing from those commercialization proceeds.

The Bayh-Dole Act adds complexity only if your instrument contains a patentable invention — which most survey questionnaires and research protocols do not.

The practical action items are straightforward: classify your IP type, check your specific award terms, engage your TTO early, disclose any potentially patentable components immediately, and structure commercial deals to transparently acknowledge the federal purpose license.

For research commercialization teams ready to build a real sales motion around their IP portfolio — try SyncGTM free. Enrich your prospect database, automate licensing outreach, and close more deals from the instruments your team worked hard to build.